RxDoctor Payments Data

Kartike Gulati, DO

Otolaryngology/Facial Plastic Surgery · Highland, INNPI 1043507908

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Aerin Medical Inc. at 27.5% of the total. 2025 is the largest year on record at $1,821, 4.8 times the $376 reported in 2019.

$6,726in general payments, 2019–2025

Across 197 payments — averaging $34.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$2K
  • Optinose US, Inc.$888
  • Spirair, Inc.$830
  • Sanofi$607
  • Advanced Bionics, LLC$379
  • Cochlear Americas$374
  • plus $2K from 13 others

What the payments were for

  • Food & beverage$6,69299%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$296,878
Medicare patients
524
Services billed
2,487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate232$3,061
Ipratropium Bromide67$2,625
Azelastine Hcl82$2,135
Ciprofloxacin Hcl95$1,806
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth13$1,206
Fluocinolone Acetonide Oil32$931
Doxycycline Hyclate66$611
Montelukast Sodium79$575
Famotidine50$415
Cephalexin93$366
Acetic Acid22$358
Pantoprazole Sodium20$340
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen66$313
Methylprednisolone43$207
Gabapentin12$191

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Highland

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →